Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Fluvoxamine for the treatment of COVID-19 –...
Journal article

Fluvoxamine for the treatment of COVID-19 – Author's reply

Authors

Reis G; Mills E

Journal

The Lancet Global Health, Vol. 10, No. 3,

Publisher

Elsevier

Publication Date

March 2022

DOI

10.1016/s2214-109x(21)00588-x

ISSN

2572-116X

Associated Experts

Edward Joseph Mills

Professor (Part-Time), Faculty of Health Sciences
Visit profile

Gilmar Reis

Associate Professor (Part-Time), Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

4202 Epidemiology4203 Health services and systems4206 Public health42 Health Sciences

Medical Subject Headings (MeSH)

FluvoxamineHumansSARS-CoV-2COVID-19 Drug Treatment
View published work (Non-McMaster Users)
View published work (McMaster Users)